SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-24
👔
CytoMed Therapeutics Ltd
@GDTC_InsiderForm 4 Filing: Choo Chee Kong Buys $300,000 of $GDTC
INSIDER PURCHASE
⚡ MATERIALITY: 6/10
corporate issuer
CytoMed Therapeutics Ltd
Ticker: $GDTC
Transaction Value
$300,000
Price/Share: $1.50
transaction date
2026-07-14
Shares: 200,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Choo Chee Kong, holds the title of Director at CytoMed Therapeutics Ltd.
On 2026-07-14, the insider transacted 200,000 shares.The shares were transacted at a weighted average price of $1.50 per share, resulting in a total market-relevant value of $300,000.
Executive Summary Summary
Choo Chee Kong (Director) bought $300K of $GDTC
Post-Transaction Position: 530,324 shares
SEC Accession No: 0001493152-26-034516 (CIK: 1970632)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.